|
|
||||||||
Clinical Investigations |
1 Third Department of Internal Medicine, Fukui Medical University, Fukui, Japan
2 Department of Radiology, Fukui Medical University, Fukui, Japan
3 Department of Fundamental Nursing, Fukui Medical University, Fukui, Japan
4 Second Department of Surgery, Fukui Medical University, Fukui, Japan
5 Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan
Recent reports have indicated the value and limitations of 18F-FDG PET and 201Tl SPECT for determination of malignancy. We prospectively assessed and compared the usefulness of these scintigraphic examinations as well as 18F-FDG PET delayed imaging for the evaluation of thoracic abnormalities. Methods: Eighty patients with thoracic nodular lesions seen on chest CT images were examined using early and delayed 18F-FDG PET and 201Tl-SPECT imaging within 1 wk of each study. The results of 18F-FDG PET and 201Tl SPECT were evaluated and compared with the histopathologic diagnosis. Results: Fifty of the lesions were histologically confirmed to be malignant, whereas 30 were benign. On 18F-FDG PET, all malignant lesions showed higher standardized uptake value (SUV) levels at 3 than at 1 h, and benign lesions revealed the opposite results. Correlations were seen between 18F-FDG PET imaging and the degree of cell differentiation in malignant tumors. No significant difference in accuracy was found between 18F-FDG PET single-time-point imaging and 201Tl SPECT for the differentiation of malignant and benign thoracic lesions. However, the retention index (RI) of 18F-FDG PET (RI-SUV) significantly improved the accuracy of thoracic lesion diagnosis. Furthermore, 18F-FDG PET delayed imaging measuring RI-SUV metastasis was useful for diagnosing nodal involvement and it improved the specificity of mediastinal staging. Conclusion: No significant difference was found between 18F-FDG PET single-time-point imaging and 201Tl SPECT for the differentiation of malignant and benign thoracic lesions. The RI calculated by 18F-FDG PET delayed imaging provided more accurate diagnoses of lung cancer.
Key Words: 18F-FDG PET 201Tl SPECT retention index lung cancer nodal staging
This article has been cited by other articles:
![]() |
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 178S - 201S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mavi, M. Urhan, J. Q. Yu, H. Zhuang, M. Houseni, T. F. Cermik, D. Thiruvenkatasamy, B. Czerniecki, M. Schnall, and A. Alavi Dual Time Point 18F-FDG PET Imaging Detects Breast Cancer with High Sensitivity and Correlates Well with Histologic Subtypes J. Nucl. Med., September 1, 2006; 47(9): 1440 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishiyama, Y. Yamamoto, K. Fukunaga, N. Kimura, A. Miki, Y. Sasakawa, H. Wakabayashi, K. Satoh, and M. Ohkawa Dual-Time-Point 18F-FDG PET for the Evaluation of Gallbladder Carcinoma J. Nucl. Med., April 1, 2006; 47(4): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, V. A. Loving, A. Chauhan, H. Zhuang, S. Mitchell, and A. Alavi Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PET J. Nucl. Med., November 1, 2005; 46(11): 1819 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer Oncologist, November 1, 2004; 9(6): 633 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Spence, M. Muzi, D. A. Mankoff, S. F. O'Sullivan, J. M. Link, T. K. Lewellen, B. Lewellen, P. Pham, S. Minoshima, K. Swanson, et al. 18F-FDG PET of Gliomas at Delayed Intervals: Improved Distinction Between Tumor and Normal Gray Matter J. Nucl. Med., October 1, 2004; 45(10): 1653 - 1659. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |